Syndax Pharmaceuticals In...

NASDAQ: SNDX · Real-Time Price · USD
15.63
0.90 (6.11%)
At close: Aug 15, 2025, 1:21 PM

Syndax Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
154.08M 295.39M 74.36M 221.97M
Short-Term Investments
418.8M 282.19M 410.04M 217.97M
Long-Term Investments
119.52M 29.83M 5.47M n/a
Other Long-Term Assets
217K 680K 9.44M n/a
Receivables
11.24M 1.23M 4.06M 429K
Inventory
366K n/a -4.25M 7.65M
Other Current Assets
10.64M 63K 8.79M 7.27M
Total Current Assets
603.06M 580.88M 481.27M 448.4M
Property-Plant & Equipment
2.02M 1.5M 1.06M 1.26M
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
121.76M 32M 15.96M 1.26M
Total Assets
724.82M 612.88M 497.24M 449.66M
Account Payables
11.63M 9.96M 4.35M 5.67M
Deferred Revenue
n/a n/a n/a 12.76M
Short-Term Debt
12.12M n/a n/a n/a
Other Current Liabilities
79.33M 35.92M 18.33M 1.89M
Total Current Liabilities
103.55M 58.1M 29.07M 20.68M
Long-Term Debt
331.56M n/a n/a 19.89M
Other Long-Term Liabilities
331.56M n/a n/a n/a
Total Long-Term Liabilities
333.14M 588K 722K 20.61M
Total Liabilities
436.69M 58.68M 29.79M 41.29M
Total Debt
345.74M 1.64M 1.16M 20.97M
Common Stock
9K 8K 7K 6K
Retained Earnings
-1.22B -902.4M -693.04M -543.7M
Comprehensive Income
163K 218K -806K 45K
Shareholders Equity
288.12M 554.2M 467.45M 408.37M
Total Investments
538.32M 312.02M 406.92M 217.97M